1.0BMJ Openhttps://blogs.bmj.com/bmjopenBMJhttps://blogs.bmj.com/bmjopen/author/admin/Editors' Picks 2015: Part Two - BMJ Openrich600338<blockquote class="wp-embedded-content" data-secret="rN7y23F1NW"><a href="https://blogs.bmj.com/bmjopen/2016/01/05/editors-picks-2015-part-two/">Editors’ Picks 2015: Part Two</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://blogs.bmj.com/bmjopen/2016/01/05/editors-picks-2015-part-two/embed/#?secret=rN7y23F1NW" width="600" height="338" title="“Editors’ Picks 2015: Part Two” — BMJ Open" data-secret="rN7y23F1NW" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://blogs.bmj.com/bmjopen/wp-includes/js/wp-embed.min.js
/* ]]> */
</script>
Clinical Trial Transparency: disclosures for new drugs below ethical and legal standards In December we surveyed our staff editors, who oversee and manage the peer review process, to tell us about their favourite articles from 2015. Part 2 looks at clinical trial transparency for new drugs. The ability of medical and healthcare professionals to select [...]Read More...https://blogs.bmj.com/bmjopen/files/2016/01/Transparency_P2-300x185.png